CoChat

Maturity-onset diabetes of the young (MODY): an update

Anık, Ahmet, Çatlı, Gönül, Abacı, Ayhan, Böber, Ece · 2015 · Journal of Pediatric Endocrinology and Metabolism

The DOI matches its Crossref record; 114 of the 118 references it cites were found in a registry or an index.

Abstract

Maturity-onset diabetes of the young (MODY) is a group of monogenic disorders characterized by autosomal dominantly inherited non-insulin dependent form of diabetes classically presenting in adolescence or young adults before the age of 25 years. MODY is a rare cause of diabetes (1% of all cases) and is frequently misdiagnosed as Type 1 diabetes (T1DM) or Type 2 diabetes (T2DM). A precise molecular diagnosis is essential because it leads to optimal treatment of the patients and allows early diagnosis for their asymptomatic family members. Mutations in the glucokinase (GCK) (MODY 2) and hepatocyte nuclear factor (HNF)1A/4A (MODY 3 and MODY 1) genes are the most common causes of MODY. GCK mutations cause a mild, asymptomatic, and stable fasting hyperglycemia usually requiring no specific treatment. However, mutations in the HNF1A and HNF4A cause a progressive pancreatic β-cell dysfunction and hyperglycemia that can result in microvascular complications. Sulfonylureas are effective in these patients by acting on adenosine triphosphate (ATP)-sensitive potassium channels, although insulin therapy may be required later in life. Mutations in the HNF1B (MODY 5) is associated with pancreatic agenesis, renal abnormalities, genital tract malformations, and liver dysfunction. Compared to MODY 1, 2, 3, and 5, the remaining subtypes of MODY have a much lower prevalence. In this review, we summarize the main clinical and laboratory characteristics of the common and rarer causes of MODY.

Overview

Integrity signals

Registry

Crossref · 10.1515/jpem-2014-0384

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 93

  1. McDonald, 2011, High - sensitivity CRP discriminates from other subtypes of diabetes, Diabetes Care, 10.2337/dc11-0323 · DOI · Paper page
  2. Spyer, 2001, AT KM Influence of maternal and fetal glucokinase mutations in gestational diabetes, Am J Obstet Gynecol, 185
  3. Hattersley, 1998, AT Maturity - onset diabetes of the young : clinical heterogeneity explained by genetic heterogeneity, Med, 15, 15
  4. Chakera, 2012, Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment, Diabetes Care, 10.2337/dc12-0151 · DOI
  5. Borowiec, 2009, Mutations at the BLK locus linked to maturity onset diabetes of the young and beta - cell dysfunction, Proc Natl Acad Sci USA, 106
  6. Fajans, 1993, MB Administration of sulfonylureas can increase glucose - induced insulin secretion for decades in patients with maturity - onset diabetes of the young, Diabetes Care, 16, 10.2337/diacare.16.9.1254 · DOI · Paper page
  7. Colom, 2010, Maturity onset diabetes of the young and pregnancy, Pract Res Clin Endocrinol Metab, 24, 605, 10.1016/j.beem.2010.05.008 · DOI
  8. Cerf, 2006, ME factors regulating beta function, Transcription cell Eur J Endocrinol, 155
  9. Schober, 2009, Phenotypical aspects of maturity - onset diabetes of the young diabetes in comparison with Type diabetes mellitus DM in children and adolescents : experience from a large multicentre database, Med, 26, 466
  10. Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
  11. Molven, 2011, PR Role of molecular genetics in transforming diagnosis of diabetes mellitus, Expert Rev Mol Diagn, 11, 313, 10.1586/erm.10.123 · DOI · Paper page
  12. Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
  13. Massa, 2001, High prevalence of glucokinase mutations in Italian children with MODY Influence on glucose tolerance first - phase insulin response insulin sensitivity and BMI, Diabetologia, 898
  14. Pearson, 2004, Contrasting diabetes phenotypes associated with hepatocyte nuclear factor alpha and beta mutations, Diabetes Care, 27, 1, 10.2337/diacare.27.5.1102 · DOI · Paper page
  15. Owen, 2002, AT Heterogeneity in young adult onset diabetes : aetiology alters clinical characteristics, Med, 19, 758
  16. Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
  17. Chen, 2010, Systematic review of anomalies in renal cysts and diabetes syndrome / maturity onset diabetes of the young type, Med Engl, 123
  18. Urbanova, 2013, Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity - onset diabetes of the young ? The case of autoimmunity - associated destruction of pancreatic beta - cells in a family of HNF MODY subjects, Int Arch Allergy, 1
  19. Stanik, 2014, De novo mutations of may be more frequent in MODY than previously assumed, Diabetologia, 1
  20. Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
  21. Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
  22. Pontoglio, 2000, alpha controls renal glucose reabsorption in mouse and man, EMBO Rep, 1
  23. Osbak, 2009, Update on mutations in glucokinase which cause maturity - onset diabetes of the young permanent neonatal diabetes and hyperinsulinemic hypoglycemia, Hum Mutat, 30, 10.1002/humu.21110 · DOI · Paper page
  24. Becker, 2014, analogues in adolescent patients with, Pediatrics, 1
  25. Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
  26. Naylor, 2011, Who should have genetic testing for maturity - onset diabetes of the young, Clin Endocrinol, 422, 10.1111/j.1365-2265.2011.04049.x · DOI
  27. Borg, 2002, Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune Type diabetes in children older than yr of age, Pediatr Diabetes, 1
  28. Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
  29. Plengvidhya, 2007, mutations in Thais with maturity onset diabetes of the young, J Clin Endocrinol Metab, 2821, 10.1210/jc.2006-1927 · DOI · Paper page
  30. Fajans, 2010, and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the mutation Pro fsX, Obesity Transl Res, 63, 1
  31. Feigerlova, 2006, Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents, Eur J Pediatr, 165
  32. Kropff, 2011, Prevalence of monogenic diabetes in young adults : a community - based cross - sectional study in Oxfordshire UK, Diabetologia, 10.1007/s00125-011-2090-z · DOI
  33. Vaxillaire, 2012, The lessons of early - onset monogenic diabetes for the understanding of diabetes pathogenesis, Pract Res Clin Endocrinol Metab, 26, 171, 10.1016/j.beem.2011.12.001 · DOI
  34. Pearson, 2003, Genetic cause of hyperglycaemia and response to treatment in diabetes, Lancet, 362
  35. Wang, 2004, The concerted activities of are essential to initiate pancreatic beta - cell differentiation, Dev Biol, 266
  36. Tattersall, 1975, SS difference between the inheritance of classical juvenile - onset and maturity - onset type diabetes of young people, Diabetes, 24
  37. Raile, 2011, caused by insulin gene INS deletion clinical characteristics of homozygous and heterozygous individuals, Diabetes Eur J Endocrinol, 165
  38. McDonald, 2011, Islet autoantibodies can discriminate maturity - onset diabetes of the young from Type diabetes, Med, 28, 1
  39. Frayling, 1997, Mutations in the hepatocyte nuclear factor - alpha gene are a common cause of maturity - onset diabetes of the young in the, Diabetes, 1
  40. Pearson, 2007, and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the gene, PLoS Med, 10.1371/journal.pmed.0040118 · DOI · Paper page
  41. Pearson, 2005, Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor alpha mutations in a large European collection, Diabetologia, 4
  42. McDonald, 2013, Maturity onset diabetes of the young identification diagnosis, Ann Clin Biochem, 15, 403, 10.1177/0004563213483458 · DOI · Paper page
  43. MODY, 1995, Ledermann HM Maturity - onset diabetes of the young at least ten times more common in Europe than previously assumed, Diabetologia
  44. Harries, 2006, AT of the TCF gene encoding hepatocyte nuclear factor - alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes, Hum Mol Genet, 15, 1, 10.1093/hmg/ddl147 · DOI · Paper page
  45. Tattersall, 1974, Mild familial diabetes with dominant inheritance, J Med, 339
  46. Schwitzgebel, 2003, Agenesis of human pancreas due to decreased half - life of insulin promoter factor, J Clin Endocrinol Metab, 1
  47. Sera, 2000, Kawasaki Identification and functional analysis of mutations in the hepatocyte nuclear factor - alpha gene in anti - islet autoantibody - negative Japanese patients with Type diabetes, J Clin Endocrinol Metab, 1
  48. Bingham, 2001, Mutations in the hepatocyte nuclear factor beta gene are associated with familial hypoplastic glomerulocystic kidney disease, Am J Hum Genet, 24, 1
  49. Stride, 2002, The genetic abnormality in the beta cell determines the response to an oral glucose load, Diabetologia, 427, 10.1007/s00125-001-0770-9 · DOI · Paper page
  50. Lambert, 2003, Identifying hepatic nuclear factor alpha mutations in children and young adults with a clinical diagnosis of Type diabetes, Diabetes Care, 26, 1, 10.2337/diacare.26.2.333 · DOI · Paper page
  51. Edghill, 2006, AT Mutations in hepatocyte nuclear factor beta and their related phenotypes, J Med Genet, 1
  52. Bowden, 2008, Triple diabetes : coexistence of Type diabetes mellitus and a novel mutation in the gene responsible for MODY in an overweight adolescent, Pediatr Diabetes, 1
  53. Tuomi, 2006, Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity - onset diabetes of the young type, Diabetes Care, 29, 189, 10.2337/diacare.29.02.06.dc05-1314 · DOI · Paper page
  54. Habener, 2005, transcriptional regulation in pancreatic development, Endocrinology, 146
  55. Leslie, 1999, GAD in Type insulin dependent diabetes, Diabetologia, 42, 10.1007/s001250051105 · DOI · Paper page
  56. Cuesta, 2010, Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene, Diabetes Care, 290, 10.2337/dc09-0681 · DOI
  57. Shepherd, 2009, AT genetic diagnosis of diabetes alters treatment and improves glycaemic control in the majority of insulin - treated patients, Med, 26, 1
  58. Velho, 1997, Identification of new glucokinase mutations and description of the clinical profile of families, Diabetologia, 14, 217, 10.1007/s001250050666 · DOI · Paper page
  59. Bonnefond, 2013, Reassessment of the putative role of loss - of - function mutation in Type diabetes, Diabetologia, 71
  60. Steele, 2013, Use of in the identification of patients with hyperglycaemia caused by a glucokinase mutation : observational case control studies One, AM, 1
  61. Kristinsson, 2001, in Iceland is associated with mutations in alpha and a novel mutation in, Diabetologia, 1
  62. Boesgaard, 2010, Further evidence that mutations in INS can be a rare cause of maturity - onset diabetes of the young, BMC Med Genet, 11
  63. Besser, 2011, RE Urinary - peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor alpha hepatocyte nuclear factor alpha maturity - onset diabetes of the young from long - duration Type diabetes, Diabetes Care, 1
  64. Colclough, 2013, Mutations in the genes encoding the transcription factors hepatocyte nuclear factor alpha alpha in maturity - onset diabetes of the young and hyperinsulinemic hypoglycemia, Hum Mutat, 1
  65. Molven, 2008, Mutations in the insulin gene can cause MODY and autoantibody - negative Type diabetes, Diabetes, 1
  66. Fajans, 2001, SS GI Molecular mechanisms and clinical pathophysiology of maturity - onset diabetes of the young, New Engl J Med, 345
  67. Edghill, 2006, Hepatocyte nuclear factor beta mutations cause neonatal diabetes and intrauterine growth retardation : support for a critical role of HNF beta in human pancreatic development, Med, 23, 1
  68. Ulinski, 2006, Renal phenotypes related to hepatocyte nuclear factor beta mutations in a pediatric cohort, J Am Soc Nephrol, 17, 497, 10.1681/asn.2005101040 · DOI · Paper page
  69. Galan, 2011, Differential effects of HNF alpha mutations associated with familial young - onset diabetes on target gene regulation, Mol Med, 17, 1, 10.2119/molmed.2010.00097 · DOI · Paper page
  70. Calcaterra, 2012, The coexistence of Type diabetes metabolic syndrome in a young girl, Acta Diabetol, 49
  71. Rubio, 2010, Homozygous mutations in are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities, Diabetes, 31, 1
  72. Neve, 2005, Role of transcription factor and its diabetes - associated gene variants in pancreatic beta cell function, Proc Natl Acad Sci USA, 11, 4807, 10.1073/pnas.0409177102 · DOI · Paper page
  73. Owen, 2010, Assessment of high - sensitivity reactive protein levels as diagnostic discriminator of maturity - onset diabetes of the young due to mutations, Diabetes Care, 24, 1
  74. Stoffers, 1997, DA Early - onset Type - II diabetes mellitus linked to, Nat Genet, 17, 1
  75. Lehto, 1999, Mutation in the HNF alpha gene affects insulin secretion and triglyceride metabolism, Diabetes, 5, 423, 10.2337/diabetes.48.2.423 · DOI
  76. Raeder, 2006, PI IS Mas Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction, Nat Genet, 38
  77. Stride, 2014, Cross - sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia, Diabetologia, 57, 54, 10.1007/s00125-013-3075-x · DOI · Paper page
  78. Owen, 2003, AT Adolescent onset Type diabetes in a non - obese Caucasian patient with an unbalanced translocation, Med, 20, 483
  79. Owen, 2011, Thanabalasingham Diagnosis and management of maturity onset diabetes of the young, Brit Med J, 343
  80. Stoffel, 1997, The maturity - onset diabetes of the young transcription factor alpha regulates expression of genes required for glucose transport and metabolism, Proc Natl Acad Sci USA, 14, 1
  81. Fajans, 2011, GI genetics pathophysiology clinical decision making, history Diabetes Care, 10.2337/dc11-0035 · DOI · Paper page
  82. Meur, 2010, Insulin gene mutations resulting in early - onset diabetes : marked differences in clinical presentation metabolic status and pathogenic effect through endoplasmic reticulum retention, Diabetes, 59
  83. Pihoker, 2013, Prevalence characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in glucokinase : results from the SEARCH for Diabetes in Youth, J Clin Endocrinol Metab, 1
  84. Horikawa, 1997, Mutation in hepatocyte nuclear factor beta gene associated with, Nat Genet, 17, 384, 10.1038/ng1297-384 · DOI · Paper page
  85. Martin, 2008, Long - term follow - up of oral glucose tolerance test - derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations, Diabetes Care, 31, 10.2337/dc07-2017 · DOI
  86. Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young - onset diabetes, Diabetologia, 10.1007/s00125-011-2418-8 · DOI · Paper page
  87. Docena, 2014, KM novel mutation and the utility of glucagon - like peptide receptor agonist therapy, Endocr Pract, 20, 1, 10.4158/ep13254.or · DOI
  88. Moller, 1998, Mutations in the hepatocyte nuclear factor - alpha gene in Caucasian families originally classified as having Type I diabetes, AM Diabetologia, 31, 1
  89. Slingerland, 2006, AS diabetes in children and young adults : challenges for researcher clinician patient, Rev, 171
  90. Dukes, 1998, ID Defective pancreatic beta - cell glycolytic signaling in hepatocyte nuclear factor alpha - deficient mice, J Biol Chem, 1
  91. Steele, 2010, AT Increased all - cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the gene, AM Med, 27, 1
  92. Igarashi, 2005, Roles of beta in kidney development and congenital cystic diseases, Kidney Int, 1
  93. Gonsorcikova, 2008, Autosomal inheritance of diabetes in two families characterized by obesity and a novel mutation in, Pediatr Diabetes, 241

Cited by

See all 246

Metadata

Authors
Anık, A., Çatlı, G., Abacı, A., & Böber, E.
Affiliations
Dokuz Eylül University (TR)
Corresponding author
Abacı, Ayhan
Venue
Journal of Pediatric Endocrinology and Metabolism
Published
2015-01-01
Volume
28
Issue
3-4
Pages
251-63
ISSN
  • 0334-018X (ISSN-L)
  • 2191-0251
OpenAlex
W1986614590
Cited by
198
References
118
Citations by year
2026: 2 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 36 · 2021: 28 · 2020: 29 · 2019: 25 · 2018: 17 · 2017: 8 · 2016: 7 · 2015: 1
FWCI
2.10
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
maturity-onset diabetes of the young, monogenic diabetes, HNF1A mutations, HNF4A mutations, HNF1B mutations, beta-cell dysfunction, pancreatic agenesis, sulfonylurea therapy, ATP-sensitive potassium channels, molecular diagnosis, fasting hyperglycemia, microvascular complications
MeSH terms
Adult, Diabetes Mellitus, Type 2, Glucokinase, Humans, Mutation, Sulfonylurea Compounds, Prevalence, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.